Irene Njuguna

Irene Njuguna

Auto-generated profile, based on publicly available information

Irene Njuguna

Kenyatta National Hospital, Nairobi, Kenya

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in The Lancet HIV
Verified
Journal Article
Closed access
INIrene N Njuguna
Irene N Njuguna
LCLisa M Cranmer
Lisa M Cranmer
VOVincent O Otieno
Vincent O Otieno
CMCyrus Mugo
Cyrus Mugo
HOHellen M Okinyi
Hellen M Okinyi
GJGrace C John-Stewart
Grace C John-Stewart

15 February 2015 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
AWAnjuli Wagner
Anjuli Wagner
JSJennifer Slyker
Jennifer Slyker
ALAgnes Langat
Agnes Langat
IIIrene Inwani
Irene Inwani
JAJudith Adhiambo
Judith Adhiambo
GJGrace John-Stewart
Grace John-Stewart
Despite expanded programs for prevention of mother-to-child HIV transmission (PMTCT), HIV-infected infants may not be diagnosed until they are ill. Comparing HIV prevalence and outcomes in infants diagnosed in PMTCT programs to those in hospital settings may improve pediatric HIV diagnosis strategies. HIV-exposed infants <12 months old were recruited from 9 PMTCT sites in public maternal child health (MCH) clinics or from an inpatient setting in Nairobi, Kenya and tested for HIV using HIV DNA assays. A subset of HIV-infected infants <4.5 months of age was enrolled in a research study and followed for 2 years. HIV prevalence, number needed to test, infant age at testing, and turnaround time for tests were compared between PMTCT programs and hospital sites. Among the enrolled cohort, baseline characteristics, survival, and timing of antiretroviral therapy (ART) initiation were compared between infants diagnosed in PMTCT programs versus hospital. Among 1,923 HIV-exposed infants, HIV prevalence was higher among infants tested in hospital than PMTCT early infant diagnosis (EID) sites (41% vs. 11%, p < 0.001); the number of HIV-exposed infants needed to test to diagnose one infection was 2.4 in the hospital vs. 9.1 in PMTCT. Receipt of HIV test results was faster among hospitalized infants (7 vs. 25 days, p < 0.001). Infants diagnosed in hospital were older at the time of testing than PMTCT diagnosed infants (5.0 vs. 1.6 months, respectively, p < 0.001). In the subset of 99 HIV-infected infants 3 times as likely to die (HR = 3.1, 95% CI = 1.3-7.6). Among HIV-exposed infants, hospital-based testing was more likely to detect an HIV-infected infant than PMTCT testing. Because young symptomatic infants diagnosed with HIV during hospitalization have very high mortality, every effort should be made to diagnose HIV infections before symptom onset. Systems to expedite turnaround time at PMTCT EID sites and to routinize inpatient pediatric HIV testing are necessary to improve pediatric HIV outcomes.

1 June 2020 in AIDS
Verified
Journal Article
Closed access
INIrene Njuguna
Irene Njuguna
JNJillian Neary
Jillian Neary
CMCaren Mburu
Caren Mburu
DBDanae Black
Danae Black
KBKristin Beima-Sofie
Kristin Beima-Sofie
GJGrace John-Stewart
Grace John-Stewart
Objectives: To determine clinic-level and individual-level correlates of viral suppression among HIV-positive adolescents and young adult (AYA) aged 10–24 years receiving antiretroviral treatment (ART). Design: Multilevel cross-sectional analysis using viral load data and facility surveys from HIV treatment programs throughout Kenya. Methods: We abstracted medical records of AYA in HIV care, analyzed the subset on ART for more than 6 months between January 2016 and December 2017, and collected information on services at each clinic. Multilevel logistic regression models were used to determine correlates of viral suppression at most recent assessment. Results: In 99 HIV clinics, among 10 096 AYA on ART more than 6 months, 2683 (27%) had unsuppressed viral load at last test. Among 16% of clinics, more than 80% of AYA were virally suppressed. Clinic-level correlates of individual viral suppression included designated adolescent spaces [aOR: 1.32, 95% CI (1.07–1.63)] and faster viral load turnaround time [aOR: 1.06 (95% CI 1.03–1.09)]. Adjusting for clinic-level factors, AYA aged 10–14 and 15–19 years had lower odds of viral suppression compared with AYA aged 20–24 years [aOR: 0.61 (0.54–0.69) and 0.59 (0.52–0.67], respectively. Compared with female patients, male patients had lower odds of viral suppression [aOR: 0.69 (0.62–0.77)]. Compared with ART duration of 6–12 months, ART for 2–5, above 5–10 or more than 10 years was associated with poor viral suppression (P < 0.001). Conclusion: Dedicated adolescent space, rapid viral load turnaround time, and tailored approaches for male individuals and perinatally infected AYA may improve viral suppression. Routine summarization of viral load suppression in clinics could provide benchmarking to motivate innovations in clinic-AYA and individual-AYA care strategies.

19 February 2020 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
INIrene Njuguna
Irene Njuguna
KBKristin Beima‐Sofie
Kristin Beima‐Sofie
CMCaren Mburu
Caren Mburu
DBDanae Black
Danae Black
YEYolanda Evans
Yolanda Evans
GJGrace John‐Stewart
Grace John‐Stewart

13 September 2019 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
INIrene Njuguna
Irene Njuguna
KBKristin Beima-Sofie
Kristin Beima-Sofie
CMCaren Mburu
Caren Mburu
CMCyrus Mugo
Cyrus Mugo
DBDanae A Black
Danae A Black
DWDalton Wamalwa
Dalton Wamalwa
Expansion of access to diagnosis and treatment for human immunodeficiency virus (HIV) and a high incidence of HIV infection in adolescence has resulted in a growing population of adolescents and young adults living with HIV. The prevalence of poor retention in care, insufficient viral suppression and loss to follow-up are higher among adolescents and young adults compared with other age groups. Poor outcomes could be attributed to psychosocial changes during adolescence, but also to poor transitional care from paediatric to adult HIV services. In many countries, transition processes remain poorly defined and unstructured, which may jeopardize treatment adherence and retention. We describe existing definitions of transition and transition frameworks, and key elements of transition as proposed by key national stakeholders in Kenya. Our consensus definition of transition is "a planned process by which adolescents and young adults living with HIV, and their caregivers, are empowered with knowledge and skills to enable them to independently manage their health." Transition should begin soon after disclosure of HIV status until an adolescent gains the necessary knowledge and skills and is willing to move to adult services, or by 25 years of age. Proposed key elements of transition are: target ages for milestone achievement; readiness assessment; caregiver involvement and communication with adult clinics; flexibility to return to adolescent or paediatric clinics; group transition; and considerations for adolescents with special needs. Retention in care, linkage to care and viral suppression are important markers of transition success. Proposed definitions and key elements could provide a framework for structuring transition programmes in other countries.

26 October 2022 in The Lancet HIV
Verified
Journal Article
Closed access
INIrene N Njuguna
Irene N Njuguna
KBKristin Beima-Sofie
Kristin Beima-Sofie
CMCaren W Mburu
Caren W Mburu
CMCyrus Mugo
Cyrus Mugo
JIJanet Itindi
Janet Itindi
GJGrace John-Stewart
Grace John-Stewart